Genolution

Genolution DSCR

The Debt Service Coverage Ratio (DSCR) of Genolution (225220.KQ) as of Nov 19, 2026 is -0.06. In the previous year, Debt Service Coverage Ratio (DSCR) was -0.05 — a change of 26.16% (lower).

DSCR

-0.06

YoY

26.16%

Last updated:

Debt Service Coverage Ratio (DSCR) of Genolution is 2024 -0.06 . Debt Service Coverage Ratio (DSCR) of Genolution was 2023 -0.05 . It decreases by 26.16% lower compared to the previous year.

The Genolution DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2018
0.09 KRW
Jan 1, 2019
-0.02 KRW
Jan 1, 2020
6.92 KRW
Jan 1, 2022
0.90 KRW
Jan 1, 2023
-0.05 KRW
Jan 1, 2024
-0.06 KRW
The Genolution DSCR history
YEARDSCRYoY
-0.06+26.16%
-0.05-105.24%
0.90-86.99%
6.92-30,585.14%
-0.02-125.27%
0.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Debt Service Coverage Ratio (DSCR) of Genolution is -0.06 in 2024.

Debt Service Coverage Ratio (DSCR) of Genolution changed from -0.05 to -0.06, representing a 26.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Genolution since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Genolution with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Genolution

All Key Metrics — Genolution